Andrew C. Saiz* and Kelsey L. Farenhem
Edited by Hannah LeBlanc and Steven Cheng
Review | Aug. 31 2023
- Decades of HIV research have paved the way for new HIV vaccines, although there remain technical challenges to produce an effective vaccine.
- Public-private partnerships have been integral in modern vaccine development, particularly for HIV.
- Several factors will impact future vaccine rollout, including healthcare data systems, vaccine sharing plans, and disparities in care accessibility.
This MIT Science Policy Review article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/ by/4.0/.